You are here

Article info

Article menu
Download PDFPDF
Clinical science
Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy

Authors

  1. Correspondence to Dr Taiichi Hikichi, Ohtsuka Eye Hospital, Kita-16 Nishi-4, Kita-ku, Sapporo 001-0016, Japan; taiichi-hikichi{at}hokkaido.med.or.jp
View Full Text

Citation

Hikichi T, Kitamei H, Shioya S
Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy
British Journal of Ophthalmology 2015;99:817-822.

Publication history

  • Received May 28, 2014
  • Revised November 4, 2014
  • Accepted November 19, 2014
  • First published December 5, 2014.
Online issue publication 
May 25, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions